| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 156 |
| 1 | ETANERCEPT | 152 |
| 2 | LEFLUNOMIDE | 151 |
| 3 | TOCILIZUMAB | 138 |
| 4 | ABATACEPT | 137 |
| 5 | METHOTREXATE | 137 |
| 6 | TOFACITINIB | 122 |
| 7 | HYDROXYCHLOROQUINE SULFATE | 109 |
| 8 | HYDROXYCHLOROQUINE | 103 |
| 9 | INFLIXIMAB | 100 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLD | 73 | 0.0127 |
| 1 | ALLOPURINOL SODIUM | 3 | 0.0054 |
| 2 | ROSUVASTATIN CALCIUM | 55 | 0.0020 |
| 3 | LEFLUNOMIDE | 151 | 0.0015 |
| 4 | SULFASALAZINE | 98 | 0.0013 |
| 5 | PERINDOPRIL ERBUMINE | 7 | 0.0013 |
| 6 | TOCILIZUMAB | 138 | 0.0012 |
| 7 | HYDROXYCHLOROQUINE SULFATE | 109 | 0.0012 |
| 8 | ABATACEPT | 137 | 0.0010 |
| 9 | PROBENECID | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 163 |
| 1 | Antirheumatic Agent [EPC] | 151 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 138 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 137 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 137 |
| 5 | Aminosalicylate [EPC] | 98 |
| 6 | Standardized Chemical Allergen [EPC] | 73 |
| 7 | Corticosteroid [EPC] | 64 |
| 8 | Purine Antimetabolite [EPC] | 53 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 39 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antirheumatic Agent [EPC] | 151 | 0.0014 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 138 | 0.0010 |
| 2 | Selective T Cell Costimulation Modulator [EPC] | 137 | 0.0010 |
| 3 | Aminosalicylate [EPC] | 98 | 0.0007 |
| 4 | Purine Antimetabolite [EPC] | 53 | 0.0005 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 137 | 0.0003 |
| 6 | Xanthine Oxidase Inhibitor [EPC] | 33 | 0.0002 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 163 | 0.0002 |
| 8 | Penem Antibacterial [EPC] | 4 | 0.0001 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 39 | 0.0001 |